(Q43678311)

25 November 2017

High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial (English)

1 reference

25 November 2017

0 references

1 reference

1 reference

cryptococcal meningitis

1 reference

1 reference

7

Linda-Gail Bekker

1 reference

25 November 2017

Thomas Harrison

9

0 references

Graeme Meintjes

object named as

Graeme Meintjes

series ordinal

3

0 references

Robin Wood

series ordinal

2

object named as

Robin Wood

1 reference

25 November 2017

Shabbar Jaffar

8

0 references

Angela Loyse

series ordinal

6

object named as

Angela Loyse

1 reference

25 November 2017

5

Annemarie Brouwer

1 reference

25 November 2017

4

Kevin Rebe

1 reference

25 November 2017

Tihana Bicanic

1

1 reference

PubMed ID

18505387

25 November 2017

language of work or name

English

0 references

publication date

1 July 2008

1 reference

Clinical Infectious Diseases

25 November 2017

1 reference

25 November 2017

47

1 reference

25 November 2017

123-130

1 reference

25 November 2017

1

1 reference

Morbidity and mortality in South African gold miners: impact of untreated disease due to human immunodeficiency virus.

25 November 2017

1 reference

Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults

21 January 2018

1 reference

Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients

21 January 2018

1 reference

Causes of death in a rural, population-based human immunodeficiency virus type 1 (HIV-1) natural history cohort in Uganda.

21 January 2018

1 reference

Pharmacokinetics and pharmacodynamics of antifungals

21 January 2018

1 reference

Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial

21 January 2018

1 reference

Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial

21 January 2018

1 reference

Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group

21 January 2018

1 reference

Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America

21 January 2018

1 reference

Early mycological treatment failure in AIDS-associated cryptococcal meningitis

21 January 2018

1 reference

Clinical pharmacokinetics of systemic antifungal drugs

21 January 2018

1 reference

Randomized comparison of amphotericin B deoxycholate dissolved in dextrose or Intralipid for the treatment of AIDS-associated cryptococcal meningitis

21 January 2018

1 reference

Amphotericin B nephrotoxicity

21 January 2018

1 reference

Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis.

21 January 2018

1 reference

Amphotericin B blunts erythropoietin response to anemia

21 January 2018

1 reference

Amphotericin B blunts erythropoietin response to hypoxia by reinforcing FIH-mediated repression of HIF-1.

21 January 2018

1 reference

Oral versus intravenous flucytosine in patients with human immunodeficiency virus-associated cryptococcal meningitis.

21 January 2018

1 reference

Managing erythropoietin hyporesponsiveness

21 January 2018

1 reference

Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions

21 January 2018

1 reference

Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS.

21 January 2018

1 reference

Outcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazole

21 January 2018

1 reference

Antiretroviral roll-out, antifungal roll-back: access to treatment for cryptococcal meningitis

21 January 2018

1 reference

Fungal Burden, Early Fungicidal Activity, and Outcome in Cryptococcal Meningitis in Antiretroviral-Naive or Antiretroviral-Experienced Patients Treated with Amphotericin B or Fluconazole

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/588792

1 reference

25 November 2017

1 reference

PubMed ID

18505387